[Subcorneal pustulosis and benign monoclonal gammopathy. Favorable response to treatment with etretinate].
D000368:Aged; D005050:Etretinate / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D006942:Hypergammaglobulinemia / Q000150:complications*; D007122:Immunoelectrophoresis; D007070:Immunoglobulin A / Q000032:analysis; D007074:Immunoglobulin G / Q000032:analysis; D007147:Immunoglobulin Light Chains / Q000032:analysis*; D007145:Immunoglobulin kappa-Chains / Q000032:analysis*; D010266:Paraproteins / Q000032:analysis*; D012871:Skin Diseases / Q000188:drug therapy / Q000209:etiology*
D007070:Immunoglobulin A; D007074:Immunoglobulin G; D007147:Immunoglobulin Light Chains; D007145:Immunoglobulin kappa-Chains; D010266:Paraproteins; D005050:Etretinate
Pustulosis subcórnea y gammapatía monoclonal benigna. Respuesta favorable al tratamiento con etretinato.